Hence, we and others have focused on the development of small molecule inhibitors of FOXM1 and have been studying how these compounds, denoted NB compounds, are able to suppress the cancer-promoting activities of FOXM1 [8–14]. This evidence concerns the gene FOXM1 and cancer.